Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin ? receptor and the tumor necrosis factor receptor

被引:0
|
作者
Martin-Vano, Susana [1 ]
Miralles-Abella, Alejandra [1 ]
Castano, Pascual [1 ]
Hurtado-Genoves, Gema [1 ]
Aguilar-Ballester, Maria [1 ]
Herrero-Cervera, Andrea [1 ]
Vinue, Angela [1 ]
Martinez-Hervas, Sergio [1 ,2 ,3 ,4 ]
Gonzalez-Navarro, Herminia [1 ,4 ,5 ]
机构
[1] INCLIVA, Inst Hlth Res, Valencia, Spain
[2] Univ Valencia, Endocrinol & Nutr Dept, Clin Hosp, Valencia, Spain
[3] Univ Valencia, Dept Med, Valencia, Spain
[4] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab CIBERDEM, Madrid, Spain
[5] Univ Valencia, Fac Med, Biochem & Mol Biol Dept, Valencia, Spain
来源
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS | 2023年 / 35卷 / 01期
关键词
Vascular smooth muscle cells; Inflammation; Lymphotoxin; Cellular plasticity; BETA-RECEPTOR; INSULIN-RESISTANCE; ATHEROSCLEROSIS; LIGHT;
D O I
10.1016/j.arteri.2022.05.003
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: Vascular smooth muscle cells (VSMCs) undergo a phenotypic-switching process during the generation of unstable atheroma plaques. In this investigation, the potential implication of the tumor necrosis factor superfamily (TNFSF) ligands, in the gene expression signature associated with VSMC plasticity was studied. Material and methods: Human aortic (ha)VSMCs were obtained commercially and treated with the cytokine TNFSF14, also called LIGHT, the lymphotoxin alpha (LTo), the heterotrimer LTo1O2 or with vehicle for 72 h. The effect of the different treatments on gene expression was ana-lyzed by quantitative PCR and included the study of genes associated with myofibroblast-like cell function, osteochondrogenesis, pluripotency, lymphorganogenesis and macrophage-like cell function. Results: HaVSMCs displayed a change in myofibroblast-like cell genes which consisted in reduced COL1A1 and TGFB1 mRNA levels when treated with LTo or LIGHT and with augmented MMP9 expression levels when treated with LTo. LTo and LIGHT treatments also diminished the expres-sion of genes associated with osteochondrogenesis and pluripotency SOX9, CKIT, and KLF4. By contrary, all the above genes were no affected by the treatment with the trimer LT'1(32. In addi-tion, haVSMC treatment with LT', LT'1(32 and LIGHT altered lymphorganogenic cytokine gene expression which consisted of augmented CCL20 and CCL21 mRNA levels by LT' and a reduc-tion in the gene expression of CCL21 and CXCL13 by LIGHT and LT'1(32 respectively. Neither, LT' or LIGHT or LT'1(32 treatments affected the expression of macrophage-like cell markers in haVSMC. Conclusions: Altogether, indicates that the TNFSF ligands through their interconnected network of signaling, are important in the preservation of VSMC identity against the acquisition of a genetic expression signature compatible with functional cellular plasticity. (c) 2022 The Author(s). Published by Elsevier Espan tilde a, S.L.U. on behalf of Sociedad Espan tilde ola de Arteriosclerosis. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [31] Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation
    Selzman, CH
    Shames, BD
    Whitehill, TA
    Harken, AH
    McIntyre, RC
    SURGERY, 1998, 124 (02) : 318 - 326
  • [32] VASCULAR SMOOTH-MUSCLE CELL THROMBIN RECEPTOR ACTIVATION AND DESENSITIZATION
    WICK, KL
    GRIENDLING, KK
    RUNGE, MS
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1210 - 1210
  • [33] Regulation of vascular smooth muscle cell migration by the hyaluronan receptor RHAMM
    Savani, RC
    Zaman, A
    PEDIATRIC RESEARCH, 2003, 53 (04) : 56A - 56A
  • [34] Influence of epidermal growth factor receptor on thromboxane receptor mediated effects in vascular smooth muscle cells
    Berger, J. S.
    Rabe, S.
    Mildenberger, S.
    Huenerberg, M.
    Schreier, B.
    Gekle, M.
    ACTA PHYSIOLOGICA, 2015, 213 : 92 - 92
  • [35] Inhibition of vascular smooth muscle cell proliferation by a novel class of fibroblast growth factor receptor antagonists
    Segev, A
    Aviezer, D
    Yayon, A
    CIRCULATION, 1998, 98 (17) : 326 - 327
  • [36] Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis
    Pantelidis, P
    Fanning, GC
    Wells, AU
    Welsh, KI
    Du Bois, RM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (06) : 1432 - 1436
  • [37] Serum starvation and growth factor receptor expression in vascular smooth muscle cells
    Zimmermann, O
    Zwaka, TP
    Marx, N
    Torzewski, M
    Bucher, A
    Guilliard, P
    Hannekum, A
    Hombach, V
    Torzewski, J
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 (02) : 157 - 165
  • [38] Tumor necrosis factor alpha improves glucose homeostasis in diabetic mice independent with tumor necrosis factor receptor 1 and tumor necrosis factor receptor 2
    Wu, Shanshan
    Dong, Kai
    Wang, Jiajia
    Bi, Yaxin
    ENDOCRINE JOURNAL, 2018, 65 (06) : 601 - 609
  • [39] Tumor necrosis factor regulates NMDA receptor-mediated airway smooth muscle contractile function and airway responsiveness
    Anaparti, Vidyanand
    Pascoe, Christopher D.
    Jha, Aruni
    Mahood, Thomas H.
    Ilarraza, Ramses
    Unruh, Helmut
    Moqbel, Redwan
    Halayko, Andrew J.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2016, 311 (02) : L467 - L480
  • [40] Platelet Derived Growth Factor Receptor Beta Activation Promotes Atheroprotective Changes in Smooth Muscle Cell Phenotype
    Newman, Alexandra A.
    Cherepanova, Olga A.
    Owens, Gary K.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36